Calculation of your study is finished. Please find your results below.

A study for a 61 year old woman who takes Azithromycin, Pentasa, Plaquenil - from FDA reports

139 females aged 61 (±5) who take the same drugs are studied. This is a personalized study for a 61 year old female patient who has Vulvovaginitis Streptococcal, Colitis Ulcerative, Late Persistent Lyme Disease. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Mar, 15, 2019

139 females aged 61 (±5) who take Azithromycin, Pentasa, Plaquenil are studied.

Number of reports submitted per year:

Azithromycin, Pentasa, Plaquenil for a 61-year old woman.

Information of the patient in this study:

  • Age: 61
  • Gender: female
  • Conditions: Vulvovaginitis Streptococcal, Colitis Ulcerative, Late Persistent Lyme Disease
  • Drugs taken:
    • Azithromycin (azithromycin)
    • Pentasa (mesalamine)
    • Plaquenil (hydroxychloroquine sulfate)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Ageusia (loss of taste functions of the tongue)
  2. Neutrophil percentage increased
  3. Electrocardiogram qt prolonged
  4. Smell - impaired
  5. Jc virus test positive
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  7. Carbon dioxide increased
  8. Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
  9. Lymphocyte percentage decreased
  10. Blood glucose increased
1 - 6 months:
6 - 12 months:
1 - 2 years:
  1. Otitis media acute (rapid inflammation of the middle ear)
  2. Psychiatric symptom
  3. Allergic rhinitis
  4. Pathological gambling
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Tracheitis (an inflammation of the trachea)
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Ear barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum)
2 - 5 years:
  1. Stress and anxiety
  2. Restless leg syndrome (a powerful urge to move your legs)
  3. Sleep apnea syndrome
  4. Drug ineffective
5 - 10 years:
10+ years:
not specified:
  1. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  2. Pleural effusion (water on the lungs)
  3. Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin)
  4. Neuropathy peripheral (surface nerve damage)
  5. Anaemia (lack of blood)
  6. Influenza like illness
  7. Osteoporosis (bones weak and more likely to break)
  8. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Chest pain

Top conditions involved for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 21 people, 15.11%
  2. High Blood Pressure : 20 people, 14.39%
  3. Osteoporosis (bones weak and more likely to break): 14 people, 10.07%
  4. Stress And Anxiety : 13 people, 9.35%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 12 people, 8.63%
  6. Pain : 12 people, 8.63%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 7.19%
  8. Preventive Health Care : 10 people, 7.19%
  9. Migraine (headache): 9 people, 6.47%
  10. Allergic Rhinitis : 8 people, 5.76%

Top co-used drugs for these people *:

  1. Nexium (48 people, 34.53%)
  2. Levaquin (41 people, 29.50%)
  3. Ambien (40 people, 28.78%)
  4. Humira (35 people, 25.18%)
  5. Prednisone (33 people, 23.74%)
  6. Diflucan (30 people, 21.58%)
  7. Zometa (27 people, 19.42%)
  8. Prilosec (26 people, 18.71%)
  9. Neurontin (25 people, 17.99%)
  10. Methotrexate (25 people, 17.99%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!